← Leaderboards
Karsten Peppel
Duke University
$4,062,655
Attributed
$4,062,655
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $386.3K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$4,062,655 · 4
By mechanism
R01$4,062,655 · 4
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Walter J Koch$36,219,689
- Neil J. Freedman$13,528,793
- Laura M Bohn$20,645,026
- George A Truskey$23,394,960
- Yehia Daaka$7,193,099
Others in their field
Top investigators on “Tumor Necrosis Factor Alpha”
- Dan M Cooper · University Of California San Diego$16,544,868
- Steven P Engebretson · Columbia University Health Sciences$11,509,123
- Craig J McClain · University Of Louisville$10,748,767
- John T McDevitt · University Of Maryland Baltimore$10,396,534
- Debra Lynn Laskin · Rutgers Biomedical And Health Sciences$10,232,985
- Cun-Yu Wang · University Of California Los Angeles$9,714,642
Research focus
Tumor Necrosis Factor AlphaVascular Smooth MuscleCell ProliferationLaboratory RabbitMitogen Activated Protein KinasePathogenic DietInflammationRestenosisGrowth InhibitorsVascular EndotheliumBlood Vessel TransplantationNonhuman Therapy EvaluationNutrition Related TagCellsCytokineGene TherapyCytokine ReceptorsDietary LipidSignal TransductionHyperplasiaMolecularPreventInsightInflammatory
Grant awards (12)
S100A1: A Novel Modulator of Myocardial Infarct Inflammation and Regeneration$382,388
R01 · FY2012 · HL · contact PI
Transgenic Targeting of Vascular G Protein Signaling$386,250
R01 · FY2010 · HL · contact PI
S100A1: A Novel Modulator of Myocardial Infarct Inflammation and Regeneration$240,643
R01 · FY2009 · HL · contact PI
Inflammation in Vein Graft Disease: A Genetic Approach$367,420
R01 · FY2007 · HL · contact PI
Inflammation in Vein Graft Disease: A Genetic Approach$366,112
R01 · FY2006 · HL · contact PI
Inflammation in Vein Graft Disease: A Genetic Approach$9,842
R01 · FY2006 · HL · contact PI
Inflammation in Vein Graft Disease: A Genetic Approach$385,000
R01 · FY2005 · HL
Inflammation in Vein Graft Disease: A Genetic Approach$385,000
R01 · FY2004 · HL
TNF-INHIBITOR GENE THERAPY FOR NEOINTIMAL HYPERPLASIA$385,000
R01 · FY2004 · HL
TNF-INHIBITOR GENE THERAPY FOR NEOINTIMAL HYPERPLASIA$385,000
R01 · FY2003 · HL
TNF-INHIBITOR GENE THERAPY FOR NEOINTIMAL HYPERPLASIA$385,000
R01 · FY2002 · HL
TNF-INHIBITOR GENE THERAPY FOR NEOINTIMAL HYPERPLASIA$385,000
R01 · FY2001 · HL